JANX 48.96 (-0.1%)
US47103J1051BiotechnologyBiotechnology

Janux Therapeutics (JANX) Stock Highlights

48.96 | -0.1%
2024-11-21 02:32:19
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.

Statistics

Range Today
47.61 49.34
Volume Today 391.5K
Range 1 Year
7.79 65.6
Volume 1 Year 161.99M
Range 3 Year
5.65 65.6
Volume 3 Year 211.11M
Range 10 Year
5.65 65.6
Volume 10 Year 234.8M

Highlights

Market Capitalization 2.83B (mid)
Floating Shares 31.79M
Current Price 48.96
Price To Earnings -47.25
Price To Revenue 168.23
Price To Book 4.3
Earnings Per Share -1.16
Payout Ratio 0%

Performance

Latest -0.1%
1 Month -2.08%
3 Months +13.41%
6 Months +2.73%
1 Year +464.06%
3 Years +173.83%
5 Years +44%
10 Years +44%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.